Echopulse® HIFU therapy enables the non-invasive thermal ablation of breast fibroadenoma.
The therapeutic ultrasound is combined with a standard ultrasound beam to control the accuracy of the treatment.
​
The automatic treatment algorithm focuses the therapeutic ultrasound on the nodule and ensures effective step-by-step ablation. The operator controls the treatment via a touch screen and always maintains full control.
The treatment takes about 30 - 45 minutes depending on the size of the BFA. For pain relief local anesthesia is sufficient. Echopulse can be operated by a single person in a nonsurgical environment.
The milk ducts are preserved and no scars tissue if formed. There are no surgical related risks like infections or hematoma.
Clinical studies have shown mean volume reduction rates 62% after 6 months and 85% after 12 months.
.
​
​
Non-invasive thermal Ablation of Breast Fibroadenoma
Literature
High-intensity focused ultrasound (HIFU) for the treatment of symptomatic breast fibroadenoma
M. Hahn et al;International Journal of Hyperthermia; 2018:
​
M. C. L. Peek et al, International Journal of Hyperthermia; 2016:
​
R. Kovatcheva et al, Journal of Therapeutic Ultrasound; 2017:
R. Kovatcheva et al, Journal of Therapeutic Ultrasound; 2015:
​
High-intensity focused ultrasound in breast pathology-
non-invasive treatment of benign and malignant lesions
B. Cavallo Marincola et al, Expert Rev. Med. Devices; 2014:
​
B. Böer et al, Der Gynäkologe – Springer Verlag; 2018
​